RepliCel Historical Income Statement

RP Stock

CAD 0.01 0.01 33.33%

Historical analysis of RepliCel Life income statement accounts such as Total Other Income Expense Net of 1.1 M, Selling General Administrative of 1.5 M, Selling And Marketing Expenses of 472 K or Gross Profit of 374.9 K can show how well RepliCel Life Sciences performed in making a profits. Evaluating RepliCel Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of RepliCel Life's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining RepliCel Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RepliCel Life Sciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About RepliCel Income Statement Analysis

RepliCel Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to RepliCel Life shareholders. The income statement also shows RepliCel investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

RepliCel Life Income Statement Chart

At this time, RepliCel Life's Interest Expense is fairly stable compared to the past year. Other Operating Expenses is likely to climb to about 2.7 M in 2024, whereas Operating Income is likely to drop (1.5 M) in 2024.

Depreciation And Amortization Other Operating Expenses Net Income Selling General Administrative Research Development Cost Of Revenue

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RepliCel Life Sciences. It is also known as RepliCel Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in RepliCel Life Sciences financial statement analysis. It represents the amount of money remaining after all of RepliCel Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Cost Of Revenue

Cost of Revenue is found on RepliCel Life Sciences income statement and represents the costs associated with goods and services RepliCel Life provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from RepliCel Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

RepliCel Life income statement Correlations

	Depreciation And Amortization	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Selling And Marketing Expenses	Gross Profit	Research Development	Cost Of Revenue	Total Revenue	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		-0.59	0.27	-0.26	-0.27	-0.27	0.27	-0.23	-0.01	-0.23	-0.2	0.37	-0.5	0.28	0.08	0.51	0.59	-0.04	0.9
Interest Expense	-0.59		-0.41	0.35	0.36	0.36	-0.41	0.43	0.28	0.45	0.11	-0.54	0.08	-0.24	-0.16	-0.14	-0.3	0.3	-0.62
Other Operating Expenses	0.27	-0.41		-0.84	-0.83	-0.83	1.0	-0.79	-0.04	-0.81	-0.25	0.93	0.46	0.21	0.74	-0.55	-0.16	-0.64	0.57
Operating Income	-0.26	0.35	-0.84		0.99	0.99	-0.84	0.96	0.16	0.96	0.49	-0.81	-0.31	0.07	-0.58	0.35	0.3	0.74	-0.47
Ebit	-0.27	0.36	-0.83	0.99		1.0	-0.83	0.93	0.1	0.93	0.55	-0.81	-0.31	-0.01	-0.53	0.35	0.22	0.67	-0.49
Ebitda	-0.27	0.36	-0.83	0.99	1.0		-0.83	0.93	0.1	0.93	0.55	-0.81	-0.31	-0.01	-0.53	0.35	0.22	0.67	-0.49
Total Operating Expenses	0.27	-0.41	1.0	-0.84	-0.83	-0.83		-0.79	-0.04	-0.81	-0.25	0.93	0.46	0.21	0.74	-0.55	-0.16	-0.64	0.57
Income Before Tax	-0.23	0.43	-0.79	0.96	0.93	0.93	-0.79		0.38	1.0	0.4	-0.74	-0.32	0.14	-0.63	0.33	0.35	0.84	-0.42
Total Other Income Expense Net	-0.01	0.28	-0.04	0.16	0.1	0.1	-0.04	0.38		0.39	0.21	0.03	-0.03	0.2	-0.3	-0.05	0.15	0.51	0.02
Net Income	-0.23	0.45	-0.81	0.96	0.93	0.93	-0.81	1.0	0.39		0.39	-0.76	-0.34	0.13	-0.66	0.34	0.35	0.85	-0.43
Income Tax Expense	-0.2	0.11	-0.25	0.49	0.55	0.55	-0.25	0.4	0.21	0.39		-0.28	0.03	-0.28	0.03	0.02	-0.25	0.09	-0.24
Selling General Administrative	0.37	-0.54	0.93	-0.81	-0.81	-0.81	0.93	-0.74	0.03	-0.76	-0.28		0.38	0.3	0.47	-0.5	-0.05	-0.51	0.64
Selling And Marketing Expenses	-0.5	0.08	0.46	-0.31	-0.31	-0.31	0.46	-0.32	-0.03	-0.34	0.03	0.38		0.02	0.47	-0.84	-0.53	-0.39	-0.24
Gross Profit	0.28	-0.24	0.21	0.07	-0.01	-0.01	0.21	0.14	0.2	0.13	-0.28	0.3	0.02		-0.19	-0.23	0.78	0.52	0.33
Research Development	0.08	-0.16	0.74	-0.58	-0.53	-0.53	0.74	-0.63	-0.3	-0.66	0.03	0.47	0.47	-0.19		-0.34	-0.4	-0.78	0.3
Cost Of Revenue	0.51	-0.14	-0.55	0.35	0.35	0.35	-0.55	0.33	-0.05	0.34	0.02	-0.5	-0.84	-0.23	-0.34		0.43	0.25	0.24
Total Revenue	0.59	-0.3	-0.16	0.3	0.22	0.22	-0.16	0.35	0.15	0.35	-0.25	-0.05	-0.53	0.78	-0.4	0.43		0.65	0.46
Net Income From Continuing Ops	-0.04	0.3	-0.64	0.74	0.67	0.67	-0.64	0.84	0.51	0.85	0.09	-0.51	-0.39	0.52	-0.78	0.25	0.65		-0.23
Reconciled Depreciation	0.9	-0.62	0.57	-0.47	-0.49	-0.49	0.57	-0.42	0.02	-0.43	-0.24	0.64	-0.24	0.33	0.3	0.24	0.46	-0.23

Click cells to compare fundamentals

RepliCel Life Account Relationship Matchups

RepliCel Life income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	2.2K	1.6K	1.1K	839.0	1.5K	1.4K
Interest Expense	141.4K	176.1K	5.5K	6.7K	149.1K	156.6K
Other Operating Expenses	3.3M	1.7M	2.7M	1.7M	1.7M	2.7M
Operating Income	(2.9M)	(1.1M)	(3.2M)	(191.4K)	(1.4M)	(1.5M)
Ebit	(2.9M)	(1.1M)	(3.2M)	(191.4K)	(1.4M)	(1.5M)
Ebitda	(2.9M)	(1.1M)	(3.2M)	(190.6K)	(1.4M)	(1.5M)
Total Operating Expenses	3.3M	1.7M	2.7M	1.7M	1.7M	2.6M
Income Before Tax	(3.0M)	(1.6M)	(4.1M)	(743.2K)	(311.7K)	(327.3K)
Total Other Income Expense Net	(77.3K)	(252.4K)	(1.8M)	656.1K	1.1M	1.1M
Net Income	(3.0M)	(1.6M)	(4.1M)	(743.2K)	(311.7K)	(327.3K)
Income Tax Expense	44.0K	183.5K	(867.9K)	1.2M	(1.0)	(1.05)
Selling General Administrative	1.1M	884.7K	1.5M	1.1M	1.2M	1.5M
Research Development	2.2M	819.4K	1.1M	624.0K	526.4K	500.1K
Net Income From Continuing Ops	(3.0M)	(1.6M)	(4.1M)	(743.2K)	(69.3K)	(72.8K)
Net Income Applicable To Common Shares	(2.8M)	(3.0M)	(1.6M)	(4.1M)	(4.7M)	(4.9M)
Net Interest Income	(92.0K)	(175.7K)	69.0	(6.7K)	(1.1K)	(1.1K)
Interest Income	92.0K	358.0	69.0	43.0	725.0	688.75
Reconciled Depreciation	2.2K	1.6K	1.1K	839.0	1.4K	1.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RepliCel Historical Income Statement

About RepliCel Income Statement Analysis

RepliCel Life Income Statement Chart

Depreciation And Amortization

Other Operating Expenses

Net Income

Cost Of Revenue

RepliCel Life income statement Correlations

RepliCel Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

RepliCel Life income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for RepliCel Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Ebit	+ 0.99	Operating Income
Ebitda	+ 0.99	Operating Income
Income Before Tax	+ 0.96	Operating Income

Cost Of Revenue	- 0.84	Selling And Marketing Expenses
Total Operating Expenses	- 0.84	Operating Income
Operating Income	- 0.84	Other Operating Expenses
Total Operating Expenses	- 0.83	Ebitda
Total Operating Expenses	- 0.83	Ebit
Ebitda	- 0.83	Other Operating Expenses